Molindone
From Anvita Health Wiki
Contents |
Introduction
- Tradename: Moban.
Indications
- symptomatic management of psychotic disorder
Contraindications
- Caution:
- cardiovascular disease
- seizure disorder
Dosage
- Tabs: 5, 10, 25, 50, 100 mg.
- Liquid: 20 mg/mL.
Pharmacokinetics
- rapidly & completely absorbed from the GI tract
- rapidly metabolized in the liver to inactive metabolites
- < 3% excreted unchanged in the urine
- elimination via liver
- elimination via kidney
Adverse-effects
- common (> 10%)
- less common (1-10%)
- depression, change in menstrual cycle, breast swelling
- uncommon (< 1%)
- tachycardia, arrhythmias, sedation, drowsiness, restlessness, anxiety, seizures, altered temperature regulation, neuroleptic malignant syndrome, hyperpigmentation, pruritis, rash, galactorrhea, gynecomastia, weight gain, dry mouth, agranulocytosis*, leukopenia#, retinal pigmentation, photosensitivity
- other
- low sedation, anticholinergic & orthostatic hypotensive effects
- extrapyramidal symptoms (moderate)
- * agranulocytosis is more common in women between 4th & 10th week of therapy
- # leukopenia generally occurs with large doses for prolonged periods
Drug-interactions
- see chlorpromazine
- molindone tablets contain CaSO4 & may inhibit absorption of:
Mechanism-of-action
- intermediate potency antipsychotic agent
- relatively selective domapine D2 receptor antagonist
- see chlorpromazine
More General Terms
Additional Terms
Internet Database
PubChem: 23897
PubChem: 27421
PubChem: 522521
References
- The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
- Kaiser Permanente Northern California Regional Drug Formulary, 1998
